| Medical and Health Sciences | 2021-2025 | 958 | GR 1 | 99.77 |
| Rheumatology | Lifetime | 231 | GR 1 | 99.08 |
| Rheumatology | 2021-2025 | 23 | GR 1 | 99.53 |
| Immunology | 2021-2025 | 270 | GR 1 | 93.50 |
| Pathology and Forensic Medicine | 2021-2025 | 449 | GR 3 | 80.91 |
| Systemic Lupus Erythematosus Research | Lifetime | 266 | GR 5 | 99.11 |
| Renal Diseases and Glomerulopathies | Lifetime | 248 | GR 1 | 98.63 |
| Platelet Disorders and Treatments | Lifetime | 289 | GR 1 | 98.18 |
| Systemic Sclerosis and Related Diseases | Lifetime | 256 | GR 4 | 97.89 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 393 | GR 6 | 97.31 |
| Vasculitis and related conditions | Lifetime | 260 | GR 1 | 97.36 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 693 | GR 8 | 97.33 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 210 | GR 1 | 95.68 |
| Liver Diseases and Immunity | Lifetime | 688 | GR 13 | 95.06 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 991 | GR 8 | 94.43 |
| Spondyloarthritis Studies and Treatments | Lifetime | 973 | GR 10 | 91.80 |
| Dermatological and COVID-19 studies | Lifetime | 596 | GR 5 | 79.89 |
| Aortic Thrombus and Embolism | Lifetime | 421 | GR 6 | 76.66 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 16 | GR 1 | 99.45 |
| Platelet Disorders and Treatments | 2021-2025 | 39 | GR 1 | 98.07 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | 2021-2025 | 24 | GR 1 | 95.72 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 41 | GR 2 | 97.19 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 89 | GR 3 | 98.31 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 141 | GR 3 | 95.08 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 241 | GR 1 | 95.34 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 244 | GR 4 | 92.92 |
| Vasculitis and related conditions | 2021-2025 | 301 | GR 2 | 90.59 |
| Hepatitis C virus research | 2021-2025 | 888 | GR 6 | 88.32 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 675 | GR 7 | 87.14 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 223 | GR 1 | 80.95 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 868 | GR 16 | 83.07 |
| Liver Diseases and Immunity | 2021-2025 | 632 | GR 12 | 82.07 |
| Lipid metabolism and disorders | 2021-2025 | 563 | GR 4 | 69.02 |
| Blood disorders and treatments | 2021-2025 | 595 | GR 3 | 68.14 |
| Adrenal Hormones and Disorders | 2021-2025 | 974 | GR 19 | 62.90 |
| Dermatological and COVID-19 studies | 2021-2025 | 656 | GR 11 | 54.32 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 544 | GR 5 | 53.16 |
